3D Port-A Catheter Model for New Staff
Launched by FU JEN CATHOLIC UNIVERSITY · May 12, 2024
Trial Information
Current as of March 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Background： Cancer patients often require long-term administration of chemotherapy drugs, nutritional supplementation, and blood transfusions. During these treatments, an implantable central venous access (port-a catheter) is often utilized to avoid the inconvenience of repeated needle insertions for treatment and to minimize the risk of medication leakage. Port-A catheters are considered a safer clinical measure. However, poor care and maintenance of the catheter can lead to complications such as infection, catheter damage, and leakage, which can even result in death. Proper care and maint...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • New nursing staff joined Fu Jen Catholic University Hospital.
- Exclusion Criteria:
- • Refused to participate in the study.
Trial Officials
Ke-Yun Chao, PhD
Principal Investigator
Fu Jen Catholic University Hospital
About Fu Jen Catholic University
Fu Jen Catholic University is a prestigious institution dedicated to advancing medical research and education. With a strong commitment to public health and clinical innovation, the university collaborates with various healthcare partners to conduct rigorous clinical trials aimed at improving patient outcomes and contributing to scientific knowledge. Leveraging its multidisciplinary expertise and state-of-the-art facilities, Fu Jen Catholic University strives to foster a research environment that supports ethical practices and the development of novel therapeutic interventions, ultimately enhancing the quality of care in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Taipei City, , Taiwan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
